41
6. Kuritzkes D, Parenti D, Ward D, Rachlis A, Wong R, Mallon K, Rich W, Jacobson M:
Filgrastim prevents severe neutropenia and reduces infective morbity in patients
with advanced HIV infection: results of a randomized, multicenter, controlled
trial. Aids 1998, 12:65-74.
7. Babalola C, Nightingale C, Nicolau D: Adjunctive efficacy of granulocyte colony-
stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in
neutropenic and non-neutropenic hosts. J Antimicrob Chemother 2004, 53:1098-
100.
8. Gough A, Clapperton M, Rolando N, Foster A, Howard J, Edmonds M: Randomized
placebo-controlled trial of granulocyte colony-stimulating factor in diabetic foot
infection. The Lancet 1997, 350:855-859.
9. Harousseau JL, Witz B, Lioure B, Berger M, Desablens B, Delain M, Guilhot F, Le
Prise PY, Abgrall JF, Deconick E, Guyotat D, Vilque JP, Casassus P, Tournilhac O,
Audhuy B, Solary E: Granulocyte colony-stimulating factor after intensive
consolidation chemotherapy in acute myeloid leukemia: Results of a randomized
trial of the group Ouest-Est leucémies aigues myeloblastiques. J Clin Oncol 2000,
18:780-787.
10. Carbonero R, Mayordomo J, Tornamira M, Brea M, Rueda A, Guillem V, Arcediano
A, Yubero A, Ribera F, Gomes C, Tres A, Peres-Gracia J, Lumbreras R, Hornedo J,
Funes H, Paz-Ares L: Granulocyte colony-stimulating factor in the treatment of
high-risk febrile neutropenia: a multicenter randomized trial. J Natl Cancer Inst
2001, 93:31-38.
11. U.S Food & Drug Administration. U.S Department of Health and Human
Services. Therapeutic Biological Products Approvals
[http://www.accessdata.fda.gov/scripts/cder/onctools/druglist.cfm]